January 17, 2019
by Merix Pharmaceutical Corp.
Merix Pharmaceutical Corp., an industry leader in the treatment of cold sores and development of phyto-pharmaceutical technology, announces its RELEEV® 1 Day Cold Sore Symptom Treatment that is available in drugstores like Walgreens, CVS, and Rite Aid, is now available in convenience stores, including 7-Eleven and soon in Circle K in the United States. RELEEV® 1 Day Cold Sore Symptom Treatment, provides fast relief to those with painful cold sores.
RELEEV® contains VIRACEA ® a proprietary botanical extract formula. Merix’ patented Echinacea Extract with the FDA approved OTC antimicrobial antiseptic Benzalkonium Chloride is the fastest healing treatment for cold sores known. In a double-blind, placebo controlled, clinical trial, VIRACEA® was found to heal cold sores in as little as one day. In laboratory testing VIRACEA® was found to be highly active against HSV-1 and HSV-2.
RELEEV® eases the pain of cold sores, relieves other symptoms, and stops skin irritation after application. Those with cold sore symptoms using RELEEV® can expect fast and complete cold sore symptom and fever blister relief. Easily used at home or on the go, RELEEV® provides convenient relief for cold sore sufferers anywhere.
For more information about RELEEV® and to find it in a drugstore or convenience store near you, visit https://www.releev.com.
About Merix Pharmaceutical Corp.
Established in 1998, Merix Pharmaceutical Corp. is a pioneering U.S. corporation with the primary mission of developing and marketing highly effective and safe medicines based upon its licensed bio-technology, Viracea.
Committed to easing the pain and suffering caused by infectious diseases while effectively treating the causative factor, and dedicated to ongoing research with emphasis on developing products, Merix utilizes its phyto-pharmaceutical technology in the area of antiviral and anti-infective medicine. It is believed, by leading healthcare professionals, that phyto-chemicals provide greater bio-availability with decreased cyto-toxicity, compared with other antiviral treatments.